title: [Blood donor hemovigilance: impact for donor and recipient safety].
abstract: Since its creation in 1993, hemovigilance has an important place for blood safety. The part concerning donors, as the name suggests, targeted on improvement of donor's safety covers in fact the two points of the transfusion chain with serious adverse events in donor, epidemiologic survey for recipients and post-donation information on the two sides. Organized management and close collaboration between the actors of the transfusion chain are necessary to ensure the effectiveness of the system.
authors.affiliation: Établissement français du sang d'Île-de-France, 122-130, rue Marcel-Hartmann, 94200 Ivry-Sur-Seine, France. lisette.hauser@efs.sante.fr
authors.forename: L
authors.initials: L
authors.lastname: Hauser
authors.forename: A
authors.initials: A
authors.lastname: Beyloune
authors.forename: M
authors.initials: M
authors.lastname: Simonet
authors.forename: P
authors.initials: P
authors.lastname: Bierling
mesh_terms: D000359:Aftercare; D001688:Biological Products / Q000009:adverse effects / Q000592:standards; D001782:Blood Donors; D058731:Blood Safety / Q000379:methods / Q000592:standards*; D001803:Blood Transfusion / Q000592:standards; D017848:Blood-Borne Pathogens; D018563:Disease Notification / Q000331:legislation & jurisprudence; D004282:Documentation / Q000592:standards; D046148:Donor Selection / Q000592:standards*; D005602:France; D006801:Humans; D017053:Infection Control / Q000331:legislation & jurisprudence / Q000458:organization & administration; D012308:Risk Management; D065227:Transfusion Reaction
chemical_list: D001688:Biological Products